Wednesday, October 14, 2026
HomeHealthcareUpdate on the merger approval process for the combination

Update on the merger approval process for the combination

[ad_1]

November 20, 2023

Please see attachment.

Contact information

Investor Relations
Anders Mohr Christensen
+45 2515 2364
[email protected]

Press Relations
Sanne Seyer-Hansen
+45 6038 6207
[email protected]

  • 2023_Update on the merger approval process for the combination of Novozymes and Chr. Hansen

[ad_2]

Source link

Ravindra Soni
Ravindra Sonihttps://businessfortnight.com
Senior journalist with 38 years of experience in print and digital media. Former Executive Editor. Founder and Editor of BusinessFortnight, covering business, economy, and policy news from Madhya Pradesh and across India.
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments